{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:44:44Z","timestamp":1790739884963,"version":"4.1.0"},"reference-count":67,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:p>Beyond its formal indications (epilepsy, bipolar disorder, and migraine), valproate sodium (VPA) is widely used in a number of other clinical conditions. Recently, however, the U.S. Food and Drug Administration (FDA) issued a warning regarding a decrease in IQ scores in children prenatally exposed to the drug. For patients with migraine, the pregnancy labeling of VPA will be changed from Category \u201cD\u201d to \u201cX.\u201d VPA products will remain in pregnancy category \u201cD\u201d for treating epilepsy and manic episodes associated with bipolar disorder. Thus, this article aims to assess (through a computerized Medline\/PubMed search) the neurobehavioral teratogenicity of valproate monotherapy, in order to evaluate alternative regulatory decisions. Reviewed information suggests a detrimental impact of antenatal valproate exposure on the global child neurodevelopment. Affected areas include not just reduced IQ scores, but also behavioral problems and a potential increase in the risk for a future diagnosis of attention-deficit\/hyperactivity disorder. An increased risk of developing autism-spectrum disorders has also been reported. Thus, in my opinion, VPA should be assigned definitively to the Category \u201cX,\u201d independent of any considerations about its clinical indications, and should be strictly avoided during pregnancy, due to the demonstrated risk of both neurobehavioral and neurocognitive teratogenicity.<\/jats:p>","DOI":"10.1017\/s1092852913000990","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T08:43:41Z","timestamp":1393404221000},"page":"305-315","source":"Crossref","is-referenced-by-count":38,"title":["Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions"],"prefix":"10.1017","volume":"19","author":[{"given":"Salvatore","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"S1092852913000990_ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)92042-8"},{"key":"S1092852913000990_ref36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2361"},{"key":"S1092852913000990_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2011.06.014"},{"key":"S1092852913000990_ref10","unstructured":"FDA Drug Safety Communication. Valproate anti-seizure products contraindicated for migraine prevention in pregnant women due to decreased IQ scores in exposed children. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm350684.htm. Accessed: July 5, 2013."},{"key":"S1092852913000990_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.05.010"},{"key":"S1092852913000990_ref50","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200207000-00009"},{"key":"S1092852913000990_ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1994.tb13180.x"},{"key":"S1092852913000990_ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2012.04.001"},{"key":"S1092852913000990_ref61","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn107"},{"key":"S1092852913000990_ref4","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23147"},{"key":"S1092852913000990_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2005.06.001"},{"key":"S1092852913000990_ref40","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617707070804"},{"key":"S1092852913000990_ref51","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90201-Y"},{"key":"S1092852913000990_ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a43eb7"},{"key":"S1092852913000990_ref65","doi-asserted-by":"publisher","DOI":"10.1111\/head.12206"},{"key":"S1092852913000990_ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0803531"},{"key":"S1092852913000990_ref35","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304270"},{"key":"S1092852913000990_ref47","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519070-00004"},{"key":"S1092852913000990_ref54","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519060-00001"},{"key":"S1092852913000990_ref29","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.029132"},{"key":"S1092852913000990_ref42","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12226"},{"key":"S1092852913000990_ref56","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23028"},{"key":"S1092852913000990_ref16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.1.15"},{"key":"S1092852913000990_ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00295.x"},{"key":"S1092852913000990_ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.05.010"},{"key":"S1092852913000990_ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1999.tb00852.x"},{"key":"S1092852913000990_ref39","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.176990"},{"key":"S1092852913000990_ref64","unstructured":"Mayo Clinic.Epilepsy and pregnancy: what you need to know. http:\/\/www.mayoclinic.com\/health\/pregnancy\/PR00123. Accessed: September 30, 2013."},{"key":"S1092852913000990_ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.08.003"},{"key":"S1092852913000990_ref43","volume-title":"Fundamentals of Biostatistics","author":"Rosner","year":"2006"},{"key":"S1092852913000990_ref30","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000154514.82948.69"},{"key":"S1092852913000990_ref41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2270"},{"key":"S1092852913000990_ref48","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.11.1985"},{"key":"S1092852913000990_ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a43e81"},{"key":"S1092852913000990_ref34","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000339399.64213.1a"},{"key":"S1092852913000990_ref37","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617710001359"},{"key":"S1092852913000990_ref38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31820d62c7"},{"key":"S1092852913000990_ref57","unstructured":"National Institute for Health and Clinical Excellence. The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care. http:\/\/www.nice.org.uk\/nicemedia\/live\/13635\/57784\/57784.pdf. Accessed: July 16, 2013."},{"key":"S1092852913000990_ref49","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi123"},{"key":"S1092852913000990_ref18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.62.1.28"},{"key":"S1092852913000990_ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.39.4.251"},{"key":"S1092852913000990_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70323-X"},{"key":"S1092852913000990_ref33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182088297"},{"key":"S1092852913000990_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.07.005"},{"key":"S1092852913000990_ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028725"},{"key":"S1092852913000990_ref25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318250d824"},{"key":"S1092852913000990_ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.08.033"},{"key":"S1092852913000990_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2006.08.007"},{"key":"S1092852913000990_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.08.001"},{"key":"S1092852913000990_ref45","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199710001-00003"},{"key":"S1092852913000990_ref46","volume-title":"Screening and Assessment: Guidelines for Identifying Young Disabled and Developmentally Vulnerable Children and Their Families","author":"Meisels","year":"1989"},{"key":"S1092852913000990_ref3","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796013000012"},{"key":"S1092852913000990_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.09.024"},{"key":"S1092852913000990_ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1994.tb13181.x"},{"key":"S1092852913000990_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.01.010"},{"key":"S1092852913000990_ref63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7085"},{"key":"S1092852913000990_ref28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq352"},{"key":"S1092852913000990_ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7367"},{"key":"S1092852913000990_ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.4290"},{"key":"S1092852913000990_ref58","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306573.32"},{"key":"S1092852913000990_ref12","unstructured":"Neurobehavioral Teratology Society. http:\/\/www.nbts.org\/about-nbts\/. Accessed February 15, 2014."},{"key":"S1092852913000990_ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02668.x"},{"key":"S1092852913000990_ref66","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6561.1557"},{"key":"S1092852913000990_ref59","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2012.670419"},{"key":"S1092852913000990_ref55","unstructured":"Flunarizine. http:\/\/db.cbg-meb.nl\/veegactie\/csp\/Flunarizine-December2010.doc. Accessed: July 14, 2013."},{"key":"S1092852913000990_ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1996.tb14137.x"},{"key":"S1092852913000990_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.10.011"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852913000990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T21:42:03Z","timestamp":1555882923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852913000990\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1092852913000990"],"URL":"https:\/\/doi.org\/10.1017\/s1092852913000990","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]}}}